Application
OR6C4 Antibody (C-term) western blot analysis in MCF-7 cell line lysates (35ug/lane).This demonstrates the OR6C4 antibody detected the OR6C4 protein (arrow).Application
OR6C4 Antibody (C-term) flow cytometric analysis of MCF-7 cells (right histogram) compared to a negative control cell (left histogram).FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.| Product Name | OR6C4 Antibody (C-term) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | OR6C4; Olfactory receptor 6C4; Olfactory receptor OR12-10 |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WBFC |
| WB:1:100~500 FC |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Alternative Names | OR6C4 Olfactory receptor 6C4 Olfactory receptor OR12-10 |
|---|---|
| Molecular Weight(MW) | 35010 Da |
| Function | Odorant receptor (Potential). |
| Tissue Specificity | This OR6C4 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 245-274 amino acids from the C-terminal region of human OR6C4. |
| Cellular Localization | Cell membrane; Multi-pass membrane protein. |
| Entrez Gene | 341418 |
|---|---|
| Nucleotide Accession | NP_001005494.1 |
Application
OR6C4 Antibody (C-term) western blot analysis in MCF-7 cell line lysates (35ug/lane).This demonstrates the OR6C4 antibody detected the OR6C4 protein (arrow).
Application
OR6C4 Antibody (C-term) flow cytometric analysis of MCF-7 cells (right histogram) compared to a negative control cell (left histogram).FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.| Application Notes | WB:1:100~500 FC |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
